Helus Pharma, Inc. (HELP)
6.11
-0.67
(-9.88%)
USD |
NASDAQ |
Nov 20, 16:00
6.18
+0.07
(+1.15%)
After-Hours: 20:00
Helus Pharma Price : 6.11 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 6.75 | 6.75 | 6.05 | 6.11 | 2.505M |
| Nov 19, 2026 | 7.00 | 7.14 | 6.51 | 6.78 | 2.055M |
| Nov 18, 2026 | 7.16 | 7.41 | 6.70 | 6.89 | 3.246M |
| Nov 17, 2026 | 7.81 | 8.07 | 7.033 | 7.20 | 3.029M |
| Nov 16, 2026 | 9.00 | 9.57 | 6.90 | 7.67 | 12.83M |
| Nov 13, 2026 | 8.91 | 9.06 | 8.504 | 8.87 | 979146.0 |
| Nov 12, 2026 | 9.07 | 9.35 | 8.78 | 8.86 | 1.117M |
| Nov 11, 2026 | 9.26 | 9.83 | 9.20 | 9.39 | 1.363M |
| Nov 10, 2026 | 9.17 | 9.39 | 8.82 | 9.07 | 1.141M |
| Nov 09, 2026 | 9.23 | 9.54 | 8.75 | 9.37 | 1.601M |
| Nov 06, 2026 | 8.63 | 9.18 | 8.53 | 8.96 | 1.210M |
| Nov 05, 2026 | 8.55 | 8.745 | 8.20 | 8.39 | 1.446M |
| Nov 04, 2026 | 9.03 | 9.33 | 8.55 | 8.68 | 1.253M |
| Nov 03, 2026 | 9.105 | 9.57 | 8.935 | 9.03 | 1.237M |
| Nov 02, 2026 | 10.80 | 10.85 | 8.32 | 8.80 | 3.889M |
| Oct 30, 2026 | 10.53 | 10.98 | 10.42 | 10.60 | 1.146M |
| Oct 29, 2026 | 10.91 | 11.30 | 10.51 | 10.71 | 790340.0 |
| Oct 28, 2026 | 10.63 | 10.93 | 10.34 | 10.91 | 664548.0 |
| Oct 27, 2026 | 10.22 | 10.77 | 9.71 | 10.52 | 1.527M |
| Oct 26, 2026 | 10.08 | 10.90 | 10.06 | 10.36 | 1.034M |
| Oct 23, 2026 | 10.50 | 10.75 | 9.87 | 10.19 | 1.895M |
| Oct 22, 2026 | 10.60 | 11.44 | 10.42 | 10.50 | 1.916M |
| Oct 21, 2026 | 11.10 | 11.66 | 10.75 | 10.78 | 936358.0 |
| Oct 20, 2026 | 10.75 | 11.74 | 10.67 | 10.94 | 2.366M |
| Oct 19, 2026 | 10.53 | 10.92 | 10.33 | 10.69 | 976407.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 1.845 |
| Milestone Pharmaceuticals, Inc. | 0.3711 |
| Appili Therapeutics, Inc. | 0.001 |
| Clearmind Medicine, Inc. | 2.630 |
| GH Research Plc | 17.53 |
Price Related Metrics
| PEG Ratio | -0.1488 |
| Price to Book Value | 1.989 |
| Earnings Yield | -69.77% |
| Market Cap | 486.05M |
| PEGY Ratio | -0.1488 |